Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Foetal haemoglobin, erythrocytes containing foetal haemoglobin, and hematological features in congolese patients with sickle cell anaemia.

Anemia·2012
Same author

[The problem of sickle cell disease in Africa].

Medecine tropicale : revue du Corps de sante colonial·2011
Same author

Two novel CD1 E alleles identified in black African individuals.

Tissue antigens·2002
Same author

Genetic variations in human fetal globin gene microsatellites and their functional relevance.

Human genetics·1999
Same author

Long-term hydroxyurea treatment in young sickle cell patients.

Current opinion in hematology·1999
Same author

[Molecular and cellular pathophysiology of sickle cell anemia].

Pathologie-biologie·1999
Same journal

The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.

Haematologia·2003
Same journal

Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.

Haematologia·2003
Same journal

Congenital methemoglobinemia due to NADH-methemoglobin reductase deficiency in three Indian families.

Haematologia·2003
Same journal

Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.

Haematologia·2003
Same journal

Vena cava superior syndrome due to sternal plasmacytoma in the course of systemic myeloma.

Haematologia·2003
Same journal

Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.

Haematologia·2003
See all related articles

Related Experiment Video

Updated: Dec 28, 2025

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.6K

New antisickling agents.

D Labie

    Haematologia
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Therapeutic strategies for sickle cell anemia aim to inhibit hemoglobin S polymerization. Approaches include targeting contact areas, altering oxygen affinity, and diluting intracellular hemoglobin S.

    More Related Videos

    Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
    08:23

    Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

    Published on: November 5, 2019

    10.3K
    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
    09:21

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

    Published on: January 18, 2018

    12.4K

    Related Experiment Videos

    Last Updated: Dec 28, 2025

    Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
    07:59

    Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

    Published on: April 4, 2022

    1.6K
    Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
    08:23

    Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry

    Published on: November 5, 2019

    10.3K
    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
    09:21

    Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

    Published on: January 18, 2018

    12.4K

    Area of Science:

    • Hematology
    • Molecular Biology
    • Pharmacology

    Background:

    • Sickle cell anemia exhibits diverse clinical severity.
    • Understanding hemoglobin S polymerization is crucial for treatment.
    • Cellular factors contribute significantly to sickle cell disease pathology.

    Purpose of the Study:

    • To explore therapeutic strategies for sickle cell anemia.
    • To identify mechanisms for impairing hemoglobin S polymerization.
    • To develop varied treatment approaches based on disease severity.

    Main Methods:

    • Investigating covalent and non-covalent agents to interfere with Hb S polymer formation.
    • Modulating Hb S oxygen affinity to reduce deoxygenation-induced changes.
    • Increasing mean corpuscular volume (MCV) to decrease mean corpuscular hemoglobin concentration (MCHC) and dilute Hb S.

    Main Results:

    • Identified three primary mechanisms to inhibit Hb S polymerization.
    • Demonstrated potential for altering disease course through these mechanisms.
    • Highlighted the role of red blood cell membrane modification in diluting Hb S.

    Conclusions:

    • Therapeutic interventions for sickle cell anemia can target Hb S polymerization.
    • A multi-pronged approach, including chemical modification and cellular manipulation, shows promise.
    • Tailoring treatments based on disease presentation is essential for effective management.